ProCE Banner Activity

Key HIV Studies Influencing Today’s Clinical Practice Following IDWeek and EACS 2023—Drs. Chloe Orkin and Darcy Wooten

Conference Coverage
Video

Expert faculty present their insights on the most clinically relevant new data from IDWeek and EACS 2023, as reported by CCO’s independent conference coverage.

Released: November 01, 2023

Share

Faculty

Chloe Orkin

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities 
Dean for Healthcare Transformation
Queen Mary University of London
Honorary Consultant Physician
Barts Health NHS Trust
London, United Kingdom

Darcy Wooten

Darcy Wooten, MD, MS

Professor of Medicine
Division of Infectious Diseases
Washington University
St Louis, Missouri

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc., Janssen Therapeutics, Division of Janssen Products, LP., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Janssen Therapeutics, Division of Janssen Products, LP

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare

Disclosure

Primary Author

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities 
Dean for Healthcare Transformation
Queen Mary University of London
Honorary Consultant Physician
Barts Health NHS Trust
London, United Kingdom

Chloe Orkin, MBChB, FRCP, MD: consultant/advisor/speaker: Gilead, GSK, Merck Sharp & Dohme, ViiV.

Darcy Wooten, MD, MS

Professor of Medicine
Division of Infectious Diseases
Washington University
St Louis, Missouri

Darcy Wooten, MD, MS, has no relevant financial relationships to disclose.